Arineta

Arineta develops and produces cardiovascular imaging solutions. Arineta's flagship product is CardioGraphe, a dedicated single-heartbeat, whole-heart cardiac CT scanner based on the company's proprietary Stereo CT technology. CardioGraphe is designed to provide comprehensive clinical information for diagnosis and therapy planning. It is optimized for imaging the entire heart and cardiovascular system with 140-mm coverage at a rotation speed of 0.24 seconds per rotation. The system uses a lower radiation dose than whole-body CT scanners. Further, the imaging based on a single heartbeat and the fast speed of the scan reduce contrast volumes and the need for a beta blocker. Clinical applications from calcium scoring to cardiac CTA and peripheral vascular imaging can be executed easily and successfully even for obese patients or those with high or unstable heart rates. CardioGraphe is distributed globally by GE Healthcare. The product has regulatory clearance in the United States, Canada, European Union, and other regions. It is installed and operates successfully in hospitals in North America, Europe, China, and Israel.

Arineta has raised $10M in total funding across 1 rounds. The company is currently at the Mature stage.

Arineta was founded in 2006 by Yosi Morik (Founder (No longer with the company)).

Arineta operates in Health Tech & Life Sciences, Medical Devices, Medical Treatment & Therapeutics, Diagnostics Devices, with core technologies in Simulation & Imaging. Target customers: Healthcare & Life Sciences, Healthcare, Providers, Commerce & Retail, Distribution Channels, Distributor.

Arineta is based in 15 Halamish St., Caesarea, 38900, Israel, Center District.